All lobbying filings
MANATT, PHELPS, AND PHILLIPS
Lobbying for DENALI THERAPEUTICS · Biopharmaceutical Company
Filing
1st Quarter - Amendment
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 15, 2025
Income
$67,500.00
What the client paid this registrant for the period.
Client based in
California
Lobbying activity
1
Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Medicaid policies that impact access to innovative treatments for pediatric rare diseases; rare disease drug development